Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States.

Keshava C, McCanlies EC, Keshava N, Wolff MS, Weston A.

Cancer Lett. 2001 Nov 8;173(1):37-41.

PMID:
11578807
2.

Her2 genotype and breast cancer progression in Korean women.

An HJ, Kim NK, Oh D, Kim SH, Park MJ, Jung MY, Kang H, Kim SG, Lee KP, Lee KS.

Pathol Int. 2005 Feb;55(2):48-52.

PMID:
15693849
4.

HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.

Tao W, Wang C, Han R, Jiang H.

Breast Cancer Res Treat. 2009 Mar;114(2):371-6. doi: 10.1007/s10549-008-0010-9. Epub 2008 Apr 26.

PMID:
18438707
5.

HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.

Zúbor P, Vojvodová A, Danko J, Kajo K, Szunyogh N, Lasabová Z, Biringer K, Visnovský J, Dókus K, Galajda P, Plank L.

Neoplasma. 2006;53(1):49-55.

PMID:
16416013
6.

HER2 polymorphism and breast cancer risk in Portugal.

Pinto D, Vasconcelos A, Costa S, Pereira D, Rodrigues H, Lopes C, Medeiros R.

Eur J Cancer Prev. 2004 Jun;13(3):177-81.

PMID:
15167216
7.

Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study.

Saadat M, Kohan L, Omidvari S.

Breast Cancer Res Treat. 2008 Oct;111(3):549-53. Epub 2007 Nov 7.

PMID:
17987379
8.

Waf-1 (p21) and p53 polymorphisms in breast cancer.

Keshava C, Frye BL, Wolff MS, McCanlies EC, Weston A.

Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):127-30. Erratum in: Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1682.

9.

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

PMID:
16807674
10.

The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.

Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1109-11.

11.

A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans.

Haiman CA, Setiawan VW, Xia LY, Le Marchand L, Ingles SA, Ursin G, Press MF, Bernstein L, John EM, Henderson BE.

Cancer Res. 2007 Apr 15;67(8):3565-8.

12.

Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.

Breast Cancer Res Treat. 2009 Mar;114(2):327-38. doi: 10.1007/s10549-008-9998-0. Epub 2008 Jul 16.

PMID:
18629629
13.

HER-2/neu Ile655Val polymorphism and the risk of breast cancer.

Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A.

Ann N Y Acad Sci. 2008 Sep;1138:84-94. doi: 10.1196/annals.1414.014.

PMID:
18837888
14.

Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.

Akisik E, Dalay N.

Exp Mol Pathol. 2004 Jun;76(3):260-3.

PMID:
15126109
15.

HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses.

Millikan RC, Hummer AJ, Wolff MS, Hishida A, Begg CB.

Breast Cancer Res Treat. 2005 Feb;89(3):309-12.

PMID:
15754131
16.

Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.

Ameyaw MM, Thornton N, McLeod HL.

J Natl Cancer Inst. 2000 Dec 6;92(23):1947. No abstract available.

17.

[The XbaI and PvuII gene polymorphisms of the estrogen receptor alpha gene in Chinese women with breast cancer].

Lu X, Li B, Wei JM, Hua B.

Zhonghua Wai Ke Za Zhi. 2005 Mar 1;43(5):290-3. Chinese.

PMID:
15842934
18.

Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.

Basham VM, Pharoah PD, Healey CS, Luben RN, Day NE, Easton DF, Ponder BA, Dunning AM.

Carcinogenesis. 2001 Nov;22(11):1797-800.

19.

Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.

Zubor P, Kajo K, Stanclova A, Szunyogh N, Galo S, Dussan CA, Minarik G, Visnovsky J, Danko J.

Eur J Cancer Prev. 2008 Feb;17(1):33-8.

PMID:
18090908
20.

P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.

Naidu R, Har YC, Taib NA.

J Exp Clin Cancer Res. 2007 Mar;26(1):133-40.

PMID:
17550142
Items per page

Supplemental Content

Write to the Help Desk